A naukri.com initiative
Bioengineer
1w
307
Image Credit: Bioengineer
Acupuncture Alleviates Nocturia Symptoms in Prostate Cancer Survivors, New Study Finds
- A recent pilot study published in JAMA Oncology highlights acupuncture as a promising treatment option for reducing nocturia symptoms in prostate cancer survivors.
- Nocturia, characterized by frequent nighttime urination, is a common and distressing issue affecting over half of prostate cancer survivors despite conventional treatments.
- The study showed that acupuncture not only decreased nocturnal urination frequency but also had fewer adverse effects compared to traditional medications like desmopressin and α-blockers.
- Acupuncture is believed to modulate the nervous system and autonomic functions to improve bladder control, offering a novel approach to managing post-cancer treatment complications.
- The trial emphasized the importance of patient-reported outcomes and safety profiles, suggesting acupuncture as a potential non-pharmacological treatment to enhance survivorship care.
- Beyond nocturia, acupuncture may positively impact sleep quality and overall physical function, essential for improving the well-being of cancer survivors.
- The research team's rigorous methodology and focus on patient-centric care provide a foundation for larger trials exploring acupuncture's efficacy in diverse populations with chronic conditions.
- While the study underscores the need for further research to establish efficacy and mechanisms, it signals a shift towards personalized and integrative approaches in urology and geriatric medicine.
- This innovative study advocates for acupuncture as a safe and effective treatment for nocturia in prostate cancer survivors, urging healthcare professionals to incorporate integrative therapies for comprehensive survivorship care.
- As the global population ages, addressing chronic symptoms through interventions like acupuncture is becoming increasingly important for enhancing patient quality of life and well-being.
- For inquiries about the study, interested individuals can contact Dr. Kevin T. Liou at Memorial Sloan Kettering Cancer Center via email at [email protected].
Read Full Article
18 Likes
For uninterrupted reading, download the app